President Donald Trump signs an executive order for new tariffs at the Rose Garden, April 2, 2025 (Andrew Leyden/NurPhoto via AP Images)

April 2, 2025 08:08 PM EDTUpdated 11:30 AM

Manufacturing

Chaotic tariff rollout leaves as many questions as answers for drugmakers

Max Bayer

Pharma Reporter

A rapid cascade of seemingly conflicting details from President Donald Trump’s tariff announcement left large drugmakers on Wednesday trying to figure out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Chaotic tariff rollout leaves as many questions as answers for drugmakers

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Trump’s broad tariffs exempt pharma — but for how long?

PIPEs, biopharma’s favorite financing vehicle, freeze amid market struggles

Another TIGIT trial fails as BeiGene scraps Phase 3 drug

FDA will consolidate to five 'shared services offices,' according to memo to Hill staffers

Sarepta, Roche pause Elevidys trials in Europe following patient death

Endpoints webinar: Inside the “One Lonza” strategy: Re-engineering the future of CDMO

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

Pharma Reporter

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Chaotic tariff rollout leaves as many questions as answers for drugmakers